Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaligia Biosciences develops non-invasive medical monitoring devices using advanced lightwave technology. Their “Good Health” platform aims to replace traditional invasive diagnostic methods with faster, more accurate, and pain-free alternatives. The company’s main R&D focus includes infectious and hematologic disease diagnostics. They have at least five products in early-stage development within the in vitro diagnostics market, including a whole blood hemoglobin analyzer that has been tested with academic collaborators. No clinical trial results or regulatory approvals are publicly available as of June 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaligia Biosciences.